Press Releases

Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change

February 28, 2024

Trinity Biotech to Present at Emerging Growth Conference

February 8, 2024

Trinity Biotech Announces Application for Early Sjogrens Syndrome Test Panel PLA Code

February 8, 2024

Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.

January 31, 2024

Trinity Biotech Announces Entry into a Letter of Intent with Bayer for a Joint Partnership to Launch a CGM Biosensor Device in China and India

January 31, 2024

Trinity Biotech Announces Q3 2023 Financial Results Business Update

January 31, 2024

Trinity Biotech Announces It Has Begun Shipments of Its New HIV Screening Test, TrinScreen HIV to Kenya

December 28, 2023

Trinity Biotech Announces Management Changes

December 27, 2023

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares

Trinity Biotech Announces Q2 2023 Financial Results

Trinity Biotech plc to Announce Q2 Fiscal Year 2023 Financial Results

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Minimum Bid Price Requirement

Trinity Biotech Announces That It Has Received 510(k) Clearance From The U.S. Food and Drug Administration for the Premier Resolution System

Trinity Biotech Announces Q1 2023 Financial Results

Trinity Biotech plc to Announce Q1 2023 Financial Results

July 4, 2023

Trinity Biotech Announces the Closing of its $30 Million Sale of its Life Sciences Supply Business to Biosynth

April 27, 2023

Trinity Biotech Announces the $30 Million Sale of its Life Sciences Supply Business to Biosynth

Trinity Biotech Announces Fourth Quarter and Fiscal Year 2022 Financial Results

March 23, 2023

Trinity Biotech Welcomes TrinScreen HIV’s Inclusion In The New Kenyan HIV Testing Algorithm

March 22, 2023

Trinity Biotech plc to Announce Q4 and Fiscal Year 2022 Financial Results

March 21, 2023